Back to Trades
Other4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$3.5M
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Aug 1, 2025
- Transaction Date
- Jul 30, 2025
- Accession Number
- 0001415889-25-020866
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 30, 2025 | Class A Ordinary Share | 45,748 | $10.36 | Exercise | $473.9K |
| Jul 30, 2025 | Class A Ordinary Share | 18,760 | $15.47 | Exercise | $290.2K |
| Jul 30, 2025 | Class A Ordinary Share | 64,508 | $29.90 | Exercise | $1.9M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 30, 2025 | Derivative | 45,748 | $10.36 | Exercise | $473.9K |
| Jul 30, 2025 | Derivative | 18,760 | $15.47 | Exercise | $290.2K |
Footnotes
- (F1)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $29.66 and $30.07. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F2)The option is fully vested and exercisable.